Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition

Published on December 23, 2021

Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.

Continue reading on website
Other news

TriMas (TRS) Closes Omega Buyout, Fortifies Packaging Business

December 23, 2021
TriMas (TRS) completes its acquisition of Omega Plastics, the third addition to its packaging platform in two years.

Citigroup (C) to Sell Philippines Consumer Bank to UnionBank

December 23, 2021
Citigroup's (C) sale of its consumer banking franchise in the Philippines will free up $300 million of allocated tangible common equity and increase tangible common equity by nearly $500 million.